Why 80% of Indian Women Have Uneven Skin Tone — And What Actually Works

Understanding melanin biology in Fitzpatrick III-V skin

Indian skin spans Fitzpatrick types III through V, which means higher baseline melanocyte activity and greater density of melanosomes distributed throughout the epidermis. Unlike Fitzpatrick I-II skin where melanosomes are clustered and degraded quickly, melanosomes in Indian skin are individually dispersed and persist longer in keratinocytes. This fundamental biological difference means that any inflammatory trigger — acne, friction, sun exposure, hormonal shifts — results in prolonged and more visible hyperpigmentation. The tyrosinase enzyme, which catalyses the rate-limiting step of melanin synthesis, is constitutively more active in darker skin tones. This is not a defect but an evolutionary adaptation for UV protection. However, it means that treatments must address not just existing pigmentation but the ongoing enzymatic overproduction that makes Indian skin prone to recurrence. Post-inflammatory hyperpigmentation (PIH) affects 94% of Indian acne patients compared to 48% of European patients with equivalent acne severity, making pigment management an inseparable component of any acne treatment protocol in the Indian context.

The treatment hierarchy: what works and in what order

The evidence-based treatment hierarchy for uneven skin tone in Indian skin follows a specific sequence. First-line: daily broad-spectrum SPF 50+ PA++++ — without this foundation, every other treatment is undermined by ongoing UV-driven melanogenesis. Second-line: tyrosinase inhibitors — tranexamic acid (3-5%), alpha arbutin (2%), and kojic acid (1-2%) inhibit melanin production at the enzymatic level. Third-line: exfoliation to clear existing pigment — mandelic acid (10%) is preferred over glycolic acid for Indian skin due to its larger molecular size, slower penetration, and significantly lower PIH risk. Fourth-line: retinoids (0.025-0.1%) accelerate cell turnover, bringing pigmented cells to the surface faster. The critical error most Indian women make is starting with the strongest treatment (chemical peels, high-strength actives) without the SPF foundation, creating a cycle of treatment-induced inflammation followed by more pigmentation. Patience is essential: visible improvement takes 8-12 weeks, and full correction of established pigmentation requires 16-24 weeks of consistent protocol adherence.

Colorism, cosmetics, and the clinical reality

It is important to distinguish between treating pathological hyperpigmentation (melasma, PIH, solar lentigines) and pursuing skin lightening for cosmetic reasons driven by colorism. The clinical approach addresses uneven tone — dark patches, acne marks, sun damage — to restore the patient's natural baseline skin colour uniformity. This is a medical intervention supported by evidence. The ingredients and protocols discussed here target aberrant melanin overproduction in specific areas, not constitutive skin colour. Dermatologists treating Indian patients must navigate this distinction carefully, as the demand for "fairness" products has historically driven the market toward harmful ingredients like mercury-containing creams and unsupervised hydroquinone use. Evidence-based treatment of uneven tone respects the patient's natural complexion while addressing genuine dermatological pathology that affects self-confidence and quality of life in measurable, validated psychometric scales.

Key ingredients · Evidence summary